Amarin Corp PLC ADR
![Amarin Corp PLC ADR](https://api.admiralmarkets.com/trade_icons/bright-128/AMRN.png)
Fermé
0.59 -1.67
Résumé
Variation du prix de l'action
24h
Min
0.58
Max
0.61
Revenu | 11M 1.5M |
---|---|
Ventes | 11M 67M |
BPA | 0.01 |
Marge bénéficiaire | 2.252 |
EBITDA | 13M 237K |
Recommandations | Vente |
---|---|
Prévisions sur 12 Mois | +63.93 upside |
Prochains Résultats | 30 oct. 2024 |
---|
Capitalisation Boursière | 8M 257M |
---|---|
Ouverture précédente | 2.26 |
Clôture précédente | 0.59 |
Score Technique
By Trading Central
Confiance
Weak Bearish Evidence
Amarin Corp PLC ADR Graphique
Actualités Associées
Comparaison
Variation de prix
Amarin Corp PLC ADR prévision
Objectif de Prix
By TipRanks
63.93% hausse
Prévisions sur 12 Mois
Moyen 1 USD 63.93%
Haut 1 USD
Bas 1 USD
Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
Éléments financiers
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$
À Propos Amarin Corp PLC ADR
Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.